
RNA’s short interest reaches 16.34 million shares on 2025-06-13
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Avidity Biosciences Inc revealed its Chief Scientific Officer Flanagan W. Michael unloaded Company’s shares for reported $0.66
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Avidity Biosciences
Avidity Biosciences Inc’s filing revealed that its Chief Program Officer Gallagher Kathleen P. unloaded Company’s shares for reported $0.19 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Avidity Biosciences Inc’s filing revealed that its Officer KATHLEEN GALLAGHER acquired Company’s shares for reported $0.18 million on Jun 02
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Avidity Biosciences
Avidity Biosciences Inc’s recent filing unveils that its Chief Program Officer Gallagher Kathleen P. unloaded Company’s shares for reported $0.19
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its